Tagworks Pharmaceuticals Funding: $65M Raised, Series A
Tagworks Pharmaceuticals is based in Nijmegen, The Netherlands. It has raised $65M in total funding. Latest round: Series A.
Tagworks Pharmaceuticals funding overview
Tagworks Pharmaceuticals is based in Nijmegen, The Netherlands. Tagworks Pharmaceuticals has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Tagworks Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Ysios Capital, Gilde Healthcare, Novartis Venture Fund, New Enterprise Associates, Lightstone Ventures, Meneldor and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Tagworks Pharmaceuticals funding
How much has Tagworks Pharmaceuticals raised?
Tagworks Pharmaceuticals has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Tagworks Pharmaceuticals?
Ysios Capital, Gilde Healthcare, Novartis Venture Fund, New Enterprise Associates, Lightstone Ventures, Meneldor are named among the investors backing Tagworks Pharmaceuticals.
What was the latest Tagworks Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Tagworks Pharmaceuticals based?
Tagworks Pharmaceuticals is based in Nijmegen, The Netherlands.
When did Tagworks Pharmaceuticals last raise?
The last disclosed Tagworks Pharmaceuticals round closed in January 2023 at Series A.
Tagworks Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Nijmegen below to benchmark round size and investor mix.
Companies related to Tagworks Pharmaceuticals (15)
